Viktor Boerlin

842 total citations
9 papers, 587 citations indexed

About

Viktor Boerlin is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Viktor Boerlin has authored 9 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Viktor Boerlin's work include Neuroendocrine Tumor Research Advances (7 papers), Pituitary Gland Disorders and Treatments (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Viktor Boerlin is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Pituitary Gland Disorders and Treatments (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Viktor Boerlin collaborates with scholars based in Switzerland, Netherlands and Italy. Viktor Boerlin's co-authors include Paolo Marzullo, Gaetano Lombardi, Ioana Lancranjan, Diego Ferone, Paolo Cappabianca, Annamaria Colao, S. Cirillo, Joost van der Hoek, Leo J. Hofland and Steven W. J. Lamberts and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and Diabetes Obesity and Metabolism.

In The Last Decade

Viktor Boerlin

9 papers receiving 558 citations

Peers

Viktor Boerlin

EDM

EPIDE

SURGE

MB

NEURO

M Montini Italy

C Augeri Italy

Marta Araujo‐Castro Spain

Francesca Pigliaru Italy

Damon S. Pierce United States

Philippe Chanson France

Alexander Dreval United States

Gloria Appolloni Italy

Alberto Ragni Italy

John F. Hennessy United States

M Montini Italy

Viktor Boerlin

744 ×1.4

EDM

246 ×1.1

EPIDE

327 ×1.5

SURGE

48 ×0.8

MB

44 ×0.8

NEURO

Citations per year, relative to Viktor Boerlin Viktor Boerlin (= 1×) peers M Montini

Countries citing papers authored by Viktor Boerlin

Since Specialization

Citations

This map shows the geographic impact of Viktor Boerlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Boerlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Boerlin more than expected).

Fields of papers citing papers by Viktor Boerlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Boerlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Boerlin. The network helps show where Viktor Boerlin may publish in the future.

Co-authorship network of co-authors of Viktor Boerlin

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Boerlin. A scholar is included among the top collaborators of Viktor Boerlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Boerlin. Viktor Boerlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Cynshi, Osamu, Reiko Tanaka, Andreas D. Christ, et al.. (2015). A novel and selective sodium‐glucose cotransporter‐2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 17(10). 984–993. 59 indexed citations

2.

Hoek, Joost van der, Aart‐Jan van der Lelij, Richard A. Feelders, et al.. (2005). The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients. Clinical Endocrinology. 63(2). 176–184. 46 indexed citations

3.

Hoek, Joost van der, Wouter W. de Herder, Richard A. Feelders, et al.. (2004). A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients. The Journal of Clinical Endocrinology & Metabolism. 89(2). 638–645. 117 indexed citations

4.

Lewis, Ian A., Gisbert Weckbecker, Herbert Schmid, et al.. (2004). The Superior Therapeutic Properties of SOM230 Originate from Unique Structural Elements. CHIMIA International Journal for Chemistry. 58(4). 222–222. 5 indexed citations

5.

Boerlin, Viktor, Joost van der Hoek, C Beglinger, et al.. (2003). New insights on SOM230, a universal somatostatin receptor ligand.. PubMed. 26(8 Suppl). 14–6. 30 indexed citations

6.

Kvols, Larry K. & Viktor Boerlin. (2002). Is there a role for octreotide in the treatment of hormone-refractory prostate cancer?. 16(9). 22–23. 1 indexed citations

7.

Colao, Annamaria, Diego Ferone, Paolo Marzullo, et al.. (2001). Long-Term Effects of Depot Long-Acting Somatostatin Analog Octreotide on Hormone Levels and Tumor Mass in Acromegaly¹. The Journal of Clinical Endocrinology & Metabolism. 86(6). 2779–2786. 212 indexed citations

8.

Colao, Annamaria, Paolo Marzullo, Diego Ferone, et al.. (2000). Cardiovascular Effects of Depot Long-Acting Somatostatin Analog Sandostatin LAR in Acromegaly*. The Journal of Clinical Endocrinology & Metabolism. 85(9). 3132–3140. 104 indexed citations

9.

Boerlin, Viktor, et al.. (1986). Analgesic activity of propyphenazone in patients with pain following oral surgery. European Journal of Clinical Pharmacology. 31(2). 127–131. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact